Complete ACA, is a three-layer amnion-chorion-amnion derived allograft
INTENDED USES: Complete ACA serves as a barrier and provide protective coverage from the surrounding environment to acute and chronic wounds.
CLAIMED BENEFITS: Complete ACA is a sterile, single use, dehydrated allograft derived from donated human amnion chorion membrane. Complete ACA dosage is per sq. cm, depending on the size of the wound. Complete ACA graft can be reapplied as needed, and is intended for external application. Following standard wound preparation, Complete ACA is applied directly to the wound. Complete ACA adheres to the wound bed without fixation.
OPTIONS: Per Square Centimeter
The addition of Skin Substitutes or Cellular or Tissue Based Products (CTPs) to certain wounds may afford a healing advantage over dressings and conservative treatments when these options appear insufficient to affect complete healing, after at least a 30 day period of comprehensive conservative therapy. There are currently a wide variety of bioengineered products available for soft tissue coverage to affect closure. • Human skin allografts are derived from donated human skin (cadavers) • Allogeneic matrices are derived from human tissue (fibroblasts or membrane) • Composite matrices are derived from human keratinocytes, fibroblasts and xenogeneic collagen • Acellular matrices are derived from xenogeneic collagen or tissue
For Medicare to cover this product, it needs to be ordered and applied by your clinician. A patient cannot purchase it directly from a Durable Medical Equipment (DME) store and receive reimbursement for it.
An invitation to view this topic will be emailed to specified recipients.
Sorry, this content is only available to registered members. Please register for FREE account to gain access.
To access this premium feature and more, upgrade to a premium plan today. Or browse to enjoy free content and tools.
WoundReference is a clinical decision support platform for experienced and new wound care clinicians at the point-of-care